Dr Reddys EBITDA

RDY -- USA Stock  

USD 37.41  0.07  0.19%

Dr Reddys ebitda fundamental analysis lookup allows you to check this and other indicators for Dr Reddys Laboratories Ltd or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Dr Reddys EBITDA Analysis

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Basic Expenses 
More About EBITDA | All Equity Analysis
Dr Reddys EBITDA  =
429.93 M
Dr Reddys ValuationFundamentalsBuy or Sell


In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Compare to competition
According to company disclosure Dr Reddys Laboratories Ltd reported earnings before interest,tax, depreciation and amortization of 429.93 M. This is 51.0% lower than that of the Healthcare sector, and 26.98% lower than that of Drug Manufacturers - Specialty & Generic industry, The EBITDA for all stocks is 88.97% higher than the company.

Did you try this?

Run CEO Directory Now


CEO Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Dr Reddys current financial ratios

Search macroaxis.com